NCT05655949 2026-04-22
Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
Beth Israel Deaconess Medical Center
Phase 2 Recruiting
Clinical Trials
20 trialsNCT04339036 2025-12-10
CapTemY90
Abramson Cancer Center at Penn Medicine
Phase 2 Recruiting
NCT05195710 2025-11-10
Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT05620771 2025-10-20
Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk
Northwestern University
Phase 2 Suspended
NCT07070076 2025-08-27
A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma
First Affiliated Hospital of Jinan University
Phase NA Recruiting
NCT04518748 2025-08-05
Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.
University of Michigan Rogel Cancer Center
Phase 1 Recruiting
NCT01349075 2025-04-29
TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma
Thomas Jefferson University
Completed
NCT04108481 2025-03-28
iRE-C
University of Iowa
Phase 1 Terminated
NCT03889093 2025-03-24
Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System
University of Minnesota
Phase NA Terminated
NCT06725121 2024-12-16
MacroTrans
University Health Network, Toronto
Phase 1/2 Recruiting
NCT06375915 2024-05-24
PM-CARE
IRCCS San Raffaele
Phase 2 Recruiting
NCT00072410 2023-10-04
Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer
Ludwig Institute for Cancer Research
Phase 1 Completed
NCT04332419 2022-06-22
Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies
Case Comprehensive Cancer Center
Phase NA Completed
NCT04790708 2021-03-10
FENET-2016
University Hospital of Ferrara
Phase NA Unknown
NCT03300401 2019-05-16
Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization
University of Southern California
Phase NA Withdrawn
NCT02787954 2018-10-18
Liver
The University of Texas Health Science Center, Houston
Terminated
NCT00846131 2016-09-15
Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma
Northwestern University
Phase 1 Completed
NCT02724436 2016-03-31
Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital
Phase NA Completed
NCT01898962 2013-07-15
Definitive Therapy for Oligometastatic Solid Malignancies
Rocky Mountain Cancer Centers
Phase 2 Unknown
NCT00766220 2013-01-03
Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver
M.D. Anderson Cancer Center
Phase 2 Withdrawn